Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2016

May 20, 2016

30870_dirs_2016-05-20_8c380215-0db4-439b-a720-96582f79b20c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2016-05-18

Reporting Person: PARSHALL B LYNNE (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-18 Non-Qualified Stock Option (right to buy) $7.61 A 20000.0 Acquired 2026-05-18 Common Stock (20000) Direct

Footnotes

F1: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 18, 2017.